Jefferies Adjusts Astellas Pharma's Price Target to 1,850 Yen From 1,700 Yen, Keeps at Hold
Jefferies Adjusts Astellas Pharma's Price Target to 1,850 Yen From 1,700 Yen, Keeps at Hold
Jefferies将安斯泰莱制药(adr)的目标价从1700日元调整至1850日元，维持持有
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册
资讯热榜
更新时间